Lilly Shares Jump On 7.9% Weight Loss Pill Eli Lilly said on Thursday its experimental pill, orforglipron, led to weight loss of nearly 8% at the highest dose and lowered blood sugar in patients with type 2 diabetes in a late-stage trial. By ryounglao|2025-04-17T10:33:19-04:00April 17, 2025|International News|0 Comments Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: ryounglao Related Posts Nvidia Breakout Puts $4 Trillion Market Value Within Reach Nvidia Breakout Puts $4 Trillion Market Value Within Reach Nike Shares Rally As Turnaround Takes Shape Amid Tariff Woes Nike Shares Rally As Turnaround Takes Shape Amid Tariff Woes Gold Heads For Weekly Loss As US And China Edge Closer To Deal Gold Heads For Weekly Loss As US And China Edge Closer To Deal US Stock Futures Rise Ahead Of Inflation Data As Investors Anticipate Dovish Fed US Stock Futures Rise Ahead Of Inflation Data As Investors Anticipate Dovish Fed Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Δ
Leave A Comment